Yttrium-90 (Y-90) radioembolization continues to be used in the treatment of colorectal cancer liver metastases (CRLMs), despite the lack of improvement in overall survival (OS) in randomized trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results